IL1B and glioma: To further understand the implications of using tumor-based exosomes to induce desired cell types in vitro, we explored the possibility that NSCs treated with exosomes from unchallenged and IL-1β-challenged U87 cells might induce expression of proteins associated with glioma such as CD133.